Literature DB >> 29276059

Clinical characteristics associated with racial disparities in endometrial cancer outcomes: A surveillance, epidemiology and end results analysis.

Shivani Sud1, Jordan Holmes2, Michael Eblan2, Ronald Chen3, Ellen Jones4.   

Abstract

OBJECTIVES: Racial disparities exist for endometrial cancer. We examined patterns of care and factors associated with poor outcomes for Black women with endometrial cancer.
METHODS: We studied 110,826 endometrial cancer patients diagnosed between 1980 and 2008 with minimum 5years follow-up in the Surveillance, Epidemiology, and End Results database. Trends over time in sociodemographics, disease characteristics and treatment factors were analyzed over four eras: 1980-1989, 1990-1999, 2000-2004, 2005-2008. Using sequential Cox proportional hazards and Fine-Gray competing risk models we determined the association between potential explanatory variables and racial disparities in all-cause mortality (ACM) and cancer-specific mortality (CSM), respectively.
RESULTS: Clinical characteristics of Black and White women were relatively constant over time. The unadjusted hazard ratio (HR) among Black women for ACM and CSM were 1.91 (95% CI 1.86-1.97) and 2.35 (95% CI 2.26-2.43), respectively. Adjustment for sociodemographics, disease presentation and surgery decreased the ACM HR to 1.29 (95% CI 1.24-1.34) and CSM HR to 1.18 (95% CI 1.11-1.26) without further decrease from controlling for radiotherapy. Black women were less likely to undergo operative management even when prescribed. Total and radical hysterectomy, and vaginal brachytherapy (VBT) were associated with improved ACM and CSM. Combination VBT and external beam radiotherapy was associated with improved ACM.
CONCLUSION: Racial disparities in endometrial cancer survival are predominantly attributable to increased advanced stage, high-grade and aggressive histologic subtype tumors and differential use of surgery in Black women. Intensified surgical and radiation treatment is associated with improved survival, raising questions about treatment adaptations that may potentially reduce survival disparities.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Healthcare disparities; Hysterectomy; Radiotherapy; SEER program; Uterine neoplasm

Mesh:

Year:  2017        PMID: 29276059     DOI: 10.1016/j.ygyno.2017.12.021

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

1.  Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population.

Authors:  Logan Corey; Michele L Cote; Julie J Ruterbusch; Alex Vezina; Ira Winer
Journal:  Am J Obstet Gynecol       Date:  2021-11-01       Impact factor: 8.661

2.  More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.

Authors:  David A Barrington; Jennifer A Sinnott; Danaye Nixon; Tasleem J Padamsee; David E Cohn; Kemi M Doll; Macarius M Donneyong; Ashley S Felix
Journal:  Am J Obstet Gynecol       Date:  2022-03-10       Impact factor: 10.693

3.  Identification of Five m6A-Related lncRNA Genes as Prognostic Markers for Endometrial Cancer Based on TCGA Database.

Authors:  Li Shan; Ye Lu; Cheng-Cheng Xiang; Xiaoli Zhu; Er-Dong Zuo; Xu Cheng
Journal:  J Immunol Res       Date:  2022-05-04       Impact factor: 4.493

Review 4.  The current clinical approach to newly diagnosed uterine cancer.

Authors:  Olga T Filippova; Mario M Leitao
Journal:  Expert Rev Anticancer Ther       Date:  2020-06-22       Impact factor: 4.512

5.  Guideline-concordant treatment is associated with improved survival among women with non-endometrioid endometrial cancer.

Authors:  Jhalak Dholakia; Elyse Llamocca; Allison Quick; Ritu Salani; Ashley S Felix
Journal:  Gynecol Oncol       Date:  2020-03-23       Impact factor: 5.482

6.  Racial disparities in survival among women with endometrial cancer in an equal access system.

Authors:  Amie B Park; Kathleen M Darcy; Chunqiao Tian; Yovanni Casablanca; Jill K Schinkel; Lindsey Enewold; Katherine A McGlynn; Craig D Shriver; Kangmin Zhu
Journal:  Gynecol Oncol       Date:  2021-07-27       Impact factor: 5.482

7.  Disparities in cancer-specific and overall survival in black women with endometrial cancer: A Medicare-SEER study.

Authors:  Daniel H Saris; Anna Jo Bodurtha Smith; Colleen Brensinger; Sarah H Kim; Ashley F Haggerty; Nawar Latif; Lori Cory; Robert L Giuntoli; Mark A Morgan; Lilie L Lin; Emily M Ko
Journal:  Gynecol Oncol Rep       Date:  2022-01-06

8.  Identification of Candidate Biomarker and Drug Targets for Improving Endometrial Cancer Racial Disparities.

Authors:  Pouya Javadian; Chao Xu; Virginie Sjoelund; Lindsay E Borden; Justin Garland; Doris Mangiaracina Benbrook
Journal:  Int J Mol Sci       Date:  2022-07-14       Impact factor: 6.208

9.  Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.

Authors:  Jinzhi Lai; Tianwen Xu; Hainan Yang
Journal:  BMC Cancer       Date:  2022-03-25       Impact factor: 4.430

10.  Impact of positive cytology in uterine serous carcinoma: A reassessment.

Authors:  Logan Corey; Juliana Fucinari; Mohamed Elshaikh; Daniel Schultz; Rami Musallam; Feras Zaiem; Fayez Daaboul; Omar Fehmi; Greg Dyson; Julie Ruterbusch; Robert Morris; Michelle L Cote; Rouba Ali-Fehmi; Sudeshna Bandyopadhyay
Journal:  Gynecol Oncol Rep       Date:  2021-07-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.